Navigation Links
Immune Design Corp. Appoints Guy F. Cipriani as Chief Business Officer
Date:10/18/2011

SEATTLE, Oct. 18, 2011 /PRNewswire/ -- Immune Design Corp. (IDC) announced today that Guy F. Cipriani, MBA will be joining the company as its new Chief Business Officer.  In the position, Mr. Cipriani will leverage more than 12 years of pharmaceutical and biotechnology industry experience to lead strategy and business development activities for the company's rapidly advancing pipeline of novel therapeutic vaccines and immunotherapies for infectious diseases, cancer and allergy.

(Logo:  http://photos.prnewswire.com/prnh/20111018/SF88252LOGO)

Most recently, he was Vice President of Business Development and a member of senior management at Cardiome Pharma Corp. in Vancouver, B.C. Canada.  Prior to Cardiome, Mr. Cipriani served as Director of Business Development for TransForm Pharmaceuticals, Inc., a biotechnology company based in Lexington, MA, that was acquired by Johnson and Johnson in April 2005. He also spent 5 years in Corporate Business Development at Eli Lilly and Company in Indianapolis, IN, and previously as a management consultant with Accenture in Chicago, IL.  Mr. Cipriani received his MBA from the Kellogg School of Management at Northwestern University and holds a B.S.E.E., High Honors from Rochester Institute of Technology.

"We are pleased to welcome Guy to our senior management team, as he is an extraordinary individual with great experience.  His demonstrated success in both biotechnology and pharmaceutical companies will be of significant value to IDC as we pursue new collaborations around our two platforms and broad strategic partnerships," said Carlos V. Paya. MD, Ph.D., Chief Executive Officer of IDC.

Mr. Cipriani commented, "I am excited to join an organization with such talented scientists and promising technologies.  I believe that IDC's platforms have tremendous partnering potential and that they can be leveraged in transactions that allow the company to advance aggressively.  I look forward to playing a key role on the senior management team as we take the company forward."

About Immune Design Corp.

Immune Design Corp. is a privately held, clinical-stage biotechnology company based in Seattle, Washington and formed in 2008 to bring together some of the world's leaders in the field of molecular immunology to develop vaccines for the treatment and prevention of infectious and malignant disease.  The company employs advanced and leading edge methods to precisely control the activation and context of antigen presentation by dendritic cells in order to shape the desired adaptive immune response.  This goal is accomplished through the application of two proprietary technology platforms that activate the immune system by distinct mechanisms.

Additional information can be found on the company's website at www.immunedesign.com.

Contact Media:
Cassie Ostrander 206-826-7901 or media@immunedesign.com


'/>"/>
SOURCE Immune Design Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Alcohol-related behavior changes -- blame your immune system
2. Immune Deficiency Foundation Launches Free Accredited Course for Nurses About Primary Immunodeficiency and Immunoglobulin Therapy
3. New HIV vaccine approach targets desirable immune cells
4. David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development
5. Inovio Pharmaceuticals Reports Long-Term Immune Responses from Therapeutic Cervical Dysplasia and Cancer DNA Vaccine
6. UCLA scientists discover new way to wake up the immune system using nano vaults to deliver drugs
7. Amgen and Xencor Enter Option Deal to Co-Develop Xencors Novel Antibody for Autoimmune Diseases
8. NIH scientists show how anthrax bacteria impair immune response
9. Immune Design Grants Adjuvant License to MedImmune
10. Adaptive TCR Launches the immunoSEQ™ Product Line - Visualizing the Immune System With Next-Generation Sequencing.
11. Major disease-vector mosquito reveals the secrets of its immune system
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... INDIANAPOLIS , Oct. 11, 2017  VMS BioMarketing, a ... of a nationwide oncology Clinical Nurse Educator (CNE) network, which ... growing need for communication among health care professionals to enhance ... physicians, nurses, office staff, and other health care professionals to ... for breast cancer. ...
(Date:10/11/2017)... ... 11, 2017 , ... A new study published in Fertility ... fresh in vitro fertilization (IVF) transfer cycles. The multi-center matched cohort ... After comparing the results from the fresh and frozen transfer cohorts, the authors ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... -- International research firm Parks Associates announced today that ... TMA 2017 Annual Meeting , October 11 in Scottsdale, Arizona ... market and how smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase ... "The residential security market has experienced continued growth, ...
Breaking Biology Technology:
(Date:7/20/2017)... 2017 Delta (NYSE: DAL ) customers now can ... at Reagan Washington National Airport (DCA). ... Delta launches biometrics to board aircraft at Reagan ... Delta,s biometric boarding pass experience that ... now integrated into the boarding process to allow eligible Delta SkyMiles Members ...
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at ... between startups and global businesses, taking place in ... startups will showcase the solutions they have built with IBM ... France is one of the most ... increase in the number of startups created between 2012 and ...
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
Breaking Biology News(10 mins):